TAKEDA

TAKEDA

Displaying 10 out of 16 results

  1. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Takeda scraps late-stage amyloidosis study

    Takeda Pharmaceutical Co Ltd said on Wednesday it would discontinue a late-stage study testing its experimental treatment for amyloidosis, as it ...
  2. FILE PHOTO: Takeda Pharmaceutical Co President and Chief Executive Officer Christophe Weber attends

    Novartis buys dry eye drug from Takeda for up to US$5.3 billion

    Novartis is buying dry-eye drug Xiidra from Takeda Pharmaceutical Co for up to US$5.3 billion as the Swiss drugmaker refreshes its ophthalmic ...
  3. FILE PHOTO: A Takeda logo is seen in its research hub in Cambridge

    US jury orders Takeda to pay Bayer US$155 million over hemophilia drug

    A U.S. jury has ordered Takeda Pharmaceutical Co's Baxalta unit to pay Bayer AG US$155.19 million for infringing a patent related to a Baxalta ...
  4. FILE PHOTO: An employee works at the new Takeda pharmaceutical company factory in Oranienburg

    Undeterred by Sanofi's stumble, Takeda takes similar path with dengue shot

    A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people ...
  5. FILE PHOTO: The logo of Takeda Pharmaceutical Co. is displayed at the company's news conferenc

    Takeda clears key hurdle as investors back US$59 billion Shire deal

    Takeda Pharmaceutical shareholders approved on Wednesday its US$59 billion takeover of London-listed Shire , a Takeda spokesman said, creating a ...
  6. FILE PHOTO: The logo of Takeda Pharmaceutical Co. is displayed at the company's news conferenc

    EU approves Takeda buying Shire, on divestment condition

    The European Commission said on Tuesday that it approved the US$62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, ...
  7. FILE PHOTO: The logo of Takeda Pharmaceutical Co. is displayed at the company's news conferenc

    Investor advisory firms back Takeda's US$62 billion deal for Shire

    Two shareholder advisory firms have backed Takeda Pharmaceutical's US$62 billion takeover offer for drugmaker Shire , dealing a blow to a group ...
  8. FILE PHOTO: The logo of Takeda Pharmaceutical Co. is displayed at the company's news conferenc

    Takeda's Shire takeover to bring US$963 million fee bonanza

    Banks, law firms and other advisers stand to earn up to US$963 million in fees from Takeda Pharmaceutical's US$62 billion takeover of drugmaker ...
  9. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Takeda sets vote date, aims to close US$62 billion Shire deal Jan. 8

    Japan's Takeda Pharmaceutical will hold an investor vote on its US$62 billion acquisition of Shire next month and aims to close the deal on Jan.
  10. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources

    EU antitrust regulators are set to approve Japanese drugmaker Takeda Pharmaceutical's US$62-billion offer for London peer Shire on condition that ...